Recent Finacing
Recent Raise
iCardiac provides a proprietary platform and services for cardiac safety assessment across drug development from first‑in‑human through Phase III, including TQT, reducing variance and cost for CROs and sponsors.
Focus Areas
Recent Investors
Funding round
Investor